Workflow
NCS Multistage Holdings, Inc. Announces Second Quarter 2025 Results
Globenewswire· 2025-07-31 20:07
Second Quarter Results Total revenues of $36.5 million, a 23% year-over-year improvementNet income of $0.9 million and diluted earnings per share of $0.34, which includes a positive impact of $1.4 million related to the release of our deferred tax valuation allowance in CanadaAdjusted EBITDA of $2.2 million, a $1.3 million year-over-year improvement $25.4 million in cash and $7.7 million of total debt as of June 30, 2025 HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (Nasdaq: NCSM) ...
iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market
Globenewswire· 2025-07-31 20:06
WOBURN, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by the Company. T ...
Stryker reports second quarter 2025 operating results
Globenewswire· 2025-07-31 20:05
Core Insights - Stryker reported a consolidated net sales of $6.0 billion for Q2 2025, reflecting an 11.1% increase compared to the previous year, with organic net sales growing by 10.2% [2][14][24] - The company experienced strong growth in its MedSurg and Neurotechnology segments, with net sales increasing by 17.3% to $3.8 billion, while Orthopaedics saw a modest growth of 2.0% to $2.2 billion [2][3][24] - Adjusted net earnings for the quarter reached $1.2 billion, marking an 11.6% increase, with adjusted earnings per diluted share rising to $3.13, up 11.4% [4][14][24] Sales Performance - Total net sales growth was driven by a combination of increased unit volume and higher prices, with organic net sales growth of 10.2% attributed to 9.7% from unit volume and 0.5% from price increases [2][24] - MedSurg and Neurotechnology segment's organic net sales increased by 11.0%, while Orthopaedics' organic net sales grew by 9.0% [2][3][24] - The U.S. market contributed significantly, with reported sales of $4.6 billion, reflecting a 12.5% increase, while international sales grew by 6.8% [24][28] Earnings Analysis - Reported net earnings for the quarter were $884 million, a 7.2% increase, with a diluted earnings per share of $2.29, up 7.0% [4][14][24] - Adjusted gross profit margin was reported at 65.4%, while adjusted operating income margin increased to 25.7%, up 110 basis points [4][14][24] - The company raised its full-year 2025 guidance, expecting organic net sales growth of 9.5% to 10.0% and adjusted net earnings per diluted share in the range of $13.40 to $13.60 [5][6] Market Outlook - Stryker anticipates a modestly favorable pricing impact and a slight positive effect from foreign exchange rates on sales and adjusted net earnings per diluted share [6][7] - The estimated net impact from tariffs in 2025 is approximately $175 million, reflecting recent updates in trade policies [7]
Zoom to Release Financial Results for the Second Quarter of Fiscal Year 2026
Globenewswire· 2025-07-31 20:05
SAN JOSE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the second quarter of fiscal year 2026 on Thursday, August 21, 2025, after the market closes. A live Zoom Webinar of the event can be accessed at 2:00 pm PT / 5:00 pm ET through Zoom’s investor relations website at https://investors.zoom.com. A replay will be available approximately two hours after the conclusion of the live event. About ZoomZoom’s mission is t ...
Synergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call Information
Globenewswire· 2025-07-31 20:05
Company Overview - Synergy CHC Corp. is a fast-growing consumer health and wellness company, providing products aimed at improving health and wellness [3] Upcoming Financial Results - The company plans to release its financial results for the second quarter ended June 30, 2025, on August 14, 2025, before market trading opens [1] - A conference call will be held at 9:00 a.m. ET / 6:00 a.m. PT with CEO Jack Ross and CFO Jaime Fickett to discuss the results [2] Product Portfolio - Synergy's brand portfolio includes FOCUSfactor, a clinically studied brain health supplement that enhances memory, concentration, and focus, and Flat Tummy, a lifestyle brand focused on women's wellness and weight management [3]
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
Globenewswire· 2025-07-31 20:05
Company expects to complete Phase 3 Aspire study in the second half of 2026 Aurora study of GTX-102 in additional ages and genotypes on track to initiate in the second half of 2025 NOVATO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the Phase 3 Aspire study evaluating GTX-102 (apazunersen) as a treatment for Angelman Syndrome is fully enrolled, with approximately 129 participants ages four to 17 with a genetically confirmed diagnosis of full m ...
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
Globenewswire· 2025-07-31 20:05
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on Thursday, August 7, 2025. The company will hold a conference call at 4:30 p.m. Eastern on Thursday, August 7, which will remain open to the public. During the conference call, the company will review its financial results and provide business updates. Partici ...
SPX Reports Second Quarter 2025 Results
Globenewswire· 2025-07-31 20:05
Core Insights - SPX Technologies, Inc. reported strong second quarter results for 2025, with significant year-over-year profit growth and strong margin performance, particularly in the HVAC segment [2][4] - The company raised its full-year 2025 guidance, expecting Adjusted EBITDA to range from $485 million to $510 million, reflecting an approximately 18% year-over-year increase at the midpoint [2][4] Financial Performance - Revenue for Q2 2025 was $552.4 million, a 10.2% increase from $501.3 million in Q2 2024 [3][4] - Operating income rose to $86.6 million, up 16.1% from $74.6 million in the same quarter last year [3][4] - Income from continuing operations increased to $52.5 million, a 16.2% rise compared to $45.2 million in Q2 2024 [3][4] - GAAP EPS for Q2 2025 was $1.10, up 14.6% from $0.96 in Q2 2024 [3][4] - Adjusted EBITDA for Q2 2025 was $126.7 million, reflecting a 16.3% increase from $108.9 million in Q2 2024 [3][4] Segment Performance - HVAC segment revenue for Q2 2025 was $376.7 million, a 5.7% increase from $356.5 million in Q2 2024, with segment income rising to $95.8 million [6][7] - Detection & Measurement segment revenue increased by 21.3% to $175.7 million, driven by both organic and inorganic growth [8][9] - The overall consolidated segment income for Q2 2025 was $135.8 million, up 15.5% from $117.6 million in Q2 2024 [32] Guidance and Outlook - The company anticipates full-year 2025 revenue to be in the range of $2.225 billion to $2.275 billion, representing a year-on-year increase of approximately 13% at the midpoint [4][13] - Adjusted EPS is expected to range from $6.35 to $6.65, reflecting a year-on-year increase of about 16% [4][13] - The HVAC segment is projected to generate revenue between $1.500 billion and $1.530 billion, while the Detection & Measurement segment is expected to bring in $725 million to $745 million [13]
Sow Good to Hold Second Quarter 2025 Conference Call on Thursday, August 14, 2025, at 10:00 a.m. ET
Globenewswire· 2025-07-31 20:05
IRVING, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, will hold a conference call on Thursday, August 14, 2025, at 10:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2025. The Company will provide its financial results in a press release prior to the conference call. Date: Thursday, August 14, 2025Time: 10:00 a.m. Eastern timeRegistration Link: https://register ...
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
Globenewswire· 2025-07-31 20:05
Company Participation - Seer, Inc. will participate in the Canaccord Genuity 45 Annual Growth Conference in Boston, MA [1] - The management is scheduled for a fireside chat on August 13 at 9:00 a.m. Eastern Time [2] Company Overview - Seer, Inc. is a pioneer in deep, unbiased proteomics, providing insights with unprecedented scale, speed, precision, and reproducibility [3] - The Proteograph Product Suite integrates proprietary engineered nanoparticles, streamlined automation, optimized consumables, and advanced analytical software [3] - Seer's technology addresses challenges faced by traditional proteomic methods, which often struggle with inconsistent data and limited throughput [3]